Posiphen is a compound under investigation in clinical trials for Alzheimer's disease. It is supplied as a pharmaceutical raw material for research and development purposes.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Posiphen?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Physostigmine salicylate
pharmaceutical raw material
Diatrizoic acid
pharmaceutical raw material
Etoposide phosphate
pharmaceutical raw material
Oxacillin sodium
pharmaceutical raw material
1-[(9H-Carbazol-4-yl)oxy]-3-{[(²H₇)propan-2-yl]amino}propan-2-ol
pharmaceutical raw material
The international HS code for Posiphen (CAS 116839-68-0) is 2933.99.
2933.99
2933 99 80
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
[(3aS,8bR)-3,4,8b-trimethyl-2,3a-dihydro-1H-pyrrolo[2,3-b]indol-7-yl] N-phenylcarbamate
PBHFNBQPZCRWQP-AZUAARDMSA-N
C[C@]12CCN([C@H]1N(C3=C2C=C(C=C3)OC(=O)NC4=CC=CC=C4)C)C
Sourcing Posiphen?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.